A descriptive work showed that Sema4D expression is higher in CD4+ T cells of SSc patients compared to HC, and this expression was associated with clinical characteristics such as anti-antibody levels, skin thickening, and inflammatory status [56]. This evidence concerns the gene CD4 and systemic sclerosis.